-
Mashup Score: 9
Irreversible electroporation (IRE) is a novel technique to treat localized prostate cancer with the aim of achieving oncological control while reducing related side effects. We present the outcomes of localized prostate cancer treated with IRE from a multi-center prospective registry. Men with histologically confirmed prostate cancer were recruited to receive IRE. All the patients were proposed…
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 33An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy - 4 month(s) ago
Accurate prediction of extraprostatic extension (EPE) is pivotal for surgical planning. Herein, we aimed to provide an updated model for predicting EPE among patients diagnosed with MRI-targeted biopsy. We analyzed a multi-institutional dataset of men with clinically localized prostate cancer diagnosed by MRI-targeted biopsy and subsequently underwent prostatectomy. To develop a side-specific…
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
🚨 A new study in Prostate Cancer and Prostatic Diseases introduces an innovative MRI-based model for predicting extraprostatic extension, enhancing surgical accuracy and nerve-sparing outcomes. 🚨#ProstateCancer #MedicalInnovation https://t.co/9xo5PLVYO8 https://t.co/1k9GFVNx4n
-
-
Mashup Score: 5Which protocol for prostate biopsies in patients with a positive MRI? Interest of systematic biopsies by sectors - 4 month(s) ago
Current prostate biopsy (PBx) protocol for prostate cancer (PCa) diagnosis is to perform systematic biopsies (SBx) combined with targeted biopsies (TBx) in case of positive MRI (i.e. PI-RADS ≥ 3). To assess the utility of performing SBx in combination with TBx, we determined the added value of SBx brought to the diagnosis of PCa according to their sextant location and MRI target characteristics….
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
🔬 **New Research Published!**🎯 "Exploring Prostate Biopsy Protocols: Systematic vs. Targeted" reveals insights into prostate cancer diagnostics" Read more about how this impacts patient care. #ProstateCancerAwareness #MedicalInnovation @AudreyZambon https://t.co/BUJNlhQXsA https://t.co/vir5h3ogMZ
-
-
Mashup Score: 2
This special collection entitled “The times have changed. Let the urologists change!” features articles recently accepted and published in Prostate Cancer and …
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
Have a look ate the new collection on LUTS and BPH management. Its time to change! @lucacindolo @cosimodenunzio #emerging #nature #bph https://t.co/Y3uFaYkkiM
-
-
Mashup Score: 0Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system - 8 month(s) ago
Prostate Cancer and Prostatic Diseases – Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system
Source: www.nature.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out our new article comparing Hugo and Da Vinci Robot, what do you prefer? https://t.co/FYX0K5e5MM #robot #davinci #hugo @E_Balestrazzi
-
-
Mashup Score: 8Physician Perception of Grade Group 1 Prostate Cancer - 9 month(s) ago
Management approaches to grade group 1 prostate cancer vary widely by geographic location, physician specialty, and nature of practice. A significant proportion of physicians still do not accept active surveillance as the standard of care despite published guidelines. Sentiments vary regarding the potential omission of “cancer” from the nomenclature grade group 1 disease.
Source: www.eu-focus.europeanurology.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @EurUrolFocus: Articles in Press: Physician Perception of Grade Group 1 Prostate Cancer https://t.co/lH67KflwVX @Saouduro @laen120er…
-
RT @EurUrolFocus: Articles in Press: Physician Perception of Grade Group 1 Prostate Cancer https://t.co/lH67KflwVX @Saouduro @laen120er…
-
-
Mashup Score: 1
Prostate Cancer and Prostatic Diseases – Quality of information and appropriateness of ChatGPT outputs for urology patients
Source: www.nature.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Is Chat GPT urological information accurate ? try to guess the accuracy! Find out more on : https://t.co/EmSTsF5vOu @GiorgioI_Russo @emildurukan @MikkelFode @Cacciamani_MD
-
-
Mashup Score: 0PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer - 11 month(s) ago
Using comprehensive plasma lipidomic profiling from men with metastatic castration-resistant prostate cancer (mCRPC), we have previously identified a poor-prognostic lipid profile associated with shorter overall survival (OS). In order to translate this biomarker into the clinic, these men must be identifiable via a clinically accessible, regulatory-compliant assay. A single regulatory-compliant…
Source: www.nature.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
PCPro is a novel circulating lipid biomarker that can identify men with metastatic castration resistant prostate cancer with a poor prognosis https://t.co/hJG9icyOFK #crpc #prostate#urology https://t.co/dbSED058Z0
-
-
Mashup Score: 0ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis - 12 month(s) ago
Patient outcomes were assessed based on a pre-biopsy ExoDx Prostate (EPI) score at 2.5 years of the 5-year follow-up of ongoing prostate biopsy Decision Impact Trial of the ExoDx Prostate (IntelliScore). Prospective, blinded, randomized, multisite clinical utility study was conducted from June 2017 to May 2018 (NCT03235687). Urine samples were collected from 1049 men (≥50 years old) with a PSA…
Source: www.nature.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Men with low-risk EPI scores remain at very low risk for HGPC diagnosis, defer biopsies at a higher rate with a longer time to biopsy https://t.co/eceEqva5Lc #pcsm #biopsy #prevention https://t.co/THrN0MGbp4
-
-
Mashup Score: 0
An informed decision regarding a treatment option requires data on its long-term efficacy and side-effect profile. While the side-effects of robotic radical prostatectomy have been well-quantified, the data on its long-term efficacy are lacking. We here provide 15-year oncological outcomes of clinically-localized prostate cancer (CLPCa) patients treated with robot-assisted laparoscopic…
Source: www.nature.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Men diagnosed with clinically-localized PCa in the contemporaneous PSA screening era and treated with RALP achieve durable long-term oncological control. Find out more at: https://t.co/tQkhzQ2Smt @sood11 #pcsm #metastatic https://t.co/kcb22Eg8nD
-
Multi-center study highlights Irreversible Electroporation (IRE) as a promising, minimally invasive treatment for localized prostate cancer. 🎯 #ProstateCancer #MedicalInnovation #Urology 🧬🔬 Find out more on: https://t.co/mt4XpMHbC3 https://t.co/W1vnAK0d2q